Literature DB >> 11073822

Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.

H Ouyang1, Lj Mou, C Luk, N Liu, J Karaskova, J Squire, M S Tsao.   

Abstract

Immortal epithelial cell lines were previously established after transduction of the HPV16-E6E7 genes into primary cultures of normal pancreatic duct epithelial cells. Single clones were isolated that demonstrated near normal genotype and phenotype. The proliferation of HPDE6-E6E7c7 and c11 cells is anchorage-dependent, and they were nontumorigenic in SCID mice. The cell lines demonstrated many phenotypes of normal pancreatic duct epithelium, including mRNA expression of carbonic anhydrase II, MUC-1, and cytokeratins 7, 8, 18, and 19. These cells have normal Ki-ras, p53, c-myc, and p16(INK4A) genotypes. Cytogenetic studies demonstrated losses of 3p, 10p12, and 13q14, the latter included the Rb1 gene. The wild-type p53 protein was detectable at very low levels consistent with the presence of E6 gene product, and the lack of functional p53 pathway was confirmed by the inability for gamma-irradiation to up-regulate p53 and p21waf1/cip1 protein. The p110/Rb protein level was also not detectable consistent with the expression of E7 protein and haploid loss of Rb1 gene. Despite this, the proliferation of both c7 and c11 cells were markedly inhibited by transforming growth factor-beta1. This was associated with up-regulation of p21cip1/waf1 but not p27kip1. Further studies showed that p130/Rb2 and cyclin D3 were expressed, suggesting that p130/Rb2 may have partially assumed the maintenance of G(1) cell cycle checkpoint regulation. These results indicate that except for the loss of p53 functional pathway, the two clones of HPDE6-E6E7 cells demonstrated a near normal genotype and phenotype of pancreatic duct epithelial cells. These cell lines will be useful for future studies on the molecular basis of pancreatic duct cell carcinogenesis and islet cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073822      PMCID: PMC1885733          DOI: 10.1016/S0002-9440(10)64800-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth.

Authors:  X Graña; J Garriga; X Mayol
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

2.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

3.  Culture of human main pancreatic duct epithelial cells.

Authors:  D Oda; C E Savard; T D Nguyen; E R Swenson; S P Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

4.  An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control.

Authors:  A Gualberto; K Aldape; K Kozakiewicz; T D Tlsty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.

Authors:  B Simon; D Bartsch; P Barth; N Prasnikar; K Münch; A Blum; R Arnold; B Göke
Journal:  Cancer Res       Date:  1998-04-15       Impact factor: 12.701

6.  Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.

Authors:  E Berezutskaya; B Yu; A Morozov; P Raychaudhuri; S Bagchi
Journal:  Cell Growth Differ       Date:  1997-12

7.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 8.  Genetic instabilities in human cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

9.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

Authors:  T Kiyono; S A Foster; J I Koop; J K McDougall; D A Galloway; A J Klingelhutz
Journal:  Nature       Date:  1998-11-05       Impact factor: 49.962

10.  Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.

Authors:  N Liu; T Furukawa; M Kobari; M S Tsao
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  152 in total

1.  Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.

Authors:  Matthew J Strouch; Eric C Cheon; Mohammad R Salabat; Seth B Krantz; Elias Gounaris; Laleh G Melstrom; Surabhi Dangi-Garimella; Edward Wang; Hidayatullah G Munshi; Khashayarsha Khazaie; David J Bentrem
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

2.  Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

Authors:  Young Bin Hong; Hyo Jin Kang; Sun Young Kwon; Hee Jeong Kim; Kun Young Kwon; Chi Heum Cho; Jong-Min Lee; Bhaskar V S Kallakury; Insoo Bae
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

3.  New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells.

Authors:  Audrey Holtzinger; Philip R Streeter; Farida Sarangi; Scott Hillborn; Maryam Niapour; Shinichiro Ogawa; Gordon Keller
Journal:  Development       Date:  2015-10-22       Impact factor: 6.868

4.  The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate.

Authors:  Ravi P Sahu; Sanjay K Srivastava
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

5.  Elaeocarpus reticulatus fruit extracts reduce viability and induce apoptosis in pancreatic cancer cells in vitro.

Authors:  Alexandria Turner; Danielle R Bond; Quan V Vuong; Anita Chalmers; Emma L Beckett; Judith Weidenhofer; Christopher J Scarlett
Journal:  Mol Biol Rep       Date:  2020-02-17       Impact factor: 2.316

6.  Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model.

Authors:  Ilaria Capua; Alessia Mercalli; Matteo S Pizzuto; Aurora Romero-Tejeda; Samantha Kasloff; Cristian De Battisti; Francesco Bonfante; Livia V Patrono; Elisa Vicenzi; Valentina Zappulli; Vito Lampasona; Annalisa Stefani; Claudio Doglioni; Calogero Terregino; Giovanni Cattoli; Lorenzo Piemonti
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34.

Authors:  B Bonito; D R P Sauter; A Schwab; M B A Djamgoz; I Novak
Journal:  Pflugers Arch       Date:  2016-10-17       Impact factor: 3.657

8.  Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.

Authors:  Junpei Yamaguchi; Mari Mino-Kenudson; Andrew S Liss; Sanjib Chowdhury; Timothy C Wang; Carlos Fernández-Del Castillo; Keith D Lillemoe; Andrew L Warshaw; Sarah P Thayer
Journal:  Gastroenterology       Date:  2016-08-12       Impact factor: 22.682

9.  An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.

Authors:  Mouad Edderkaoui; Chintan Chheda; Badr Soufi; Fouzia Zayou; Robert W Hu; V Krishnan Ramanujan; Xinlei Pan; Laszlo G Boros; Jian Tajbakhsh; Anisha Madhav; Neil A Bhowmick; Qiang Wang; Michael Lewis; Richard Tuli; Aida Habtezion; Ramachandran Murali; Stephen J Pandol
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

10.  Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.

Authors:  Renyuan Zhou; Reneé Shanas; Mark A Nelson; Achyut Bhattacharyya; Jiaqi Shi
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.